Prev

Kolon Life Science Advances ESG Commitment by Joining the UN Global Compact

KOLON Life Science

2026.11.12

▷ Holds membership certificate presentation ceremony at UN Global Compact Network Korea, affirming support for the Ten Principles on human rights, labour, the environment, and anti-corruption
▷ Strengthens carbon reduction and supply chain ESG management, building on EcoVadis Gold recognition and ISO certifications

Kolon Life Science has joined the United Nations Global Compact (UNGC), accelerating its commitment to responsible business practices worldwide. The company plans to integrate the UNGC’s Ten Principles into its management and business operations and further advance its sustainability performance in line with international standards.

Kolon Life Science held a membership certificate presentation ceremony on November 11 at the UN Global Compact Network Korea office in Jung-gu, Seoul. Attendees included Han-gook Lee, CEO of Kolon Life Science, and Yeon-chul Yoo, Secretary-General of UN Global Compact Network Korea. The company received final approval for its membership from UNGC headquarters on October 6, local time.

Launched under the leadership of the United Nations in 2000, the UNGC is the world’s largest corporate sustainability initiative. It encourages companies to embed its Ten Principles across four areas—human rights, labour, the environment, and anti-corruption—into their strategies and operations, contributing to the achievement of the UN Sustainable Development Goals (SDGs). The initiative currently brings together approximately 25,000 member companies across some 160 countries.

By joining the initiative, Kolon Life Science formally affirms its support for internationally recognized principles of responsible business and its commitment to putting them into practice throughout its operations. As a UNGC participant, the company will submit an annual Communication on Progress (CoP) to transparently share its progress in implementing the Ten Principles with stakeholders. Its first CoP will be submitted in 2027.

Kolon Life Science supplies active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and specialty chemicals to customers in Korea and overseas, while also developing cell and gene therapies. As global customers increasingly require compliance with ESG standards throughout their supply chains, the company plans to use its UNGC membership as an opportunity to bring its environmental, human rights, ethics, and compliance management systems into line with international standards, tailoring them to the characteristics of each business and strengthening trust among customers and partners.

Kolon Life Science has steadily strengthened the foundations of its ESG management. Last year, the company obtained international certifications for its anti-bribery management system (ISO 37001) and compliance management system (ISO 37301) and published its first sustainability report. Its second report, released in July this year, disclosed its ESG performance and strategic direction. In the assessment conducted by global sustainability ratings provider EcoVadis, the company advanced from a Silver Medal last year to a Gold Medal this year, placing it among the top 5% of companies assessed.

The company has also defined its next priorities. In the environmental area, it will work toward its medium-term target of reducing Scope 1 and 2 greenhouse gas emissions by 5% by 2030 compared with 2024 levels. In supply chain management, it plans to expand ESG self-assessments and on-site audits of key suppliers based on its Supplier Code of Conduct and implement responsible sourcing practices, including its principle of not using conflict minerals. The company will also enhance its ESG data management systems, including product carbon footprint (PCF) calculations in response to customer requests.

Yeon-chul Yoo, Secretary-General of UN Global Compact Network Korea, stated, “The pharmaceutical and biotechnology industry plays an important role in improving human health and quality of life, making responsible management across R&D, manufacturing, and supply chains increasingly important.” He added, “We hope that joining the UNGC will provide an opportunity for Kolon Life Science to further strengthen its sustainability management and contribute to achieving the SDGs.”

Han-gook Lee, CEO of Kolon Life Science, stated, “Joining the UNGC is more than an expression of support for international principles; it is a commitment to putting them into practice throughout our management and business operations.” He added, “By embedding the Ten Principles across our entire value chain, from raw material sourcing to manufacturing and R&D, we will build a foundation for sustainable growth that our global customers and partners can trust.”

#Business

KOLON Group's mobile web is optimized for vertical screens.

23%